Arava
Rheumatoid Arthritis can be a long and painful enduring disease that affects the joints of an individual. It is usually the elderly that suffers from Rheumatoid arthritis but there are isolated cases of younger people who do suffer from it as well. It is a disease where the immune system attacks the joints, thus causing the inflammation and the pain associated with rheumatoid arthritis. This disease can eventuality result to loss of movement and destruction of the joints.
Although there are more cases of rheumatoid arthritis concerning joints in the fingers, knees and other limbs, there are also cases that it can affect the lungs, heart, skin, blood vessels and muscles. Symptoms of rheumatoid arthritis are inflammation, swelling of the soft tissue and involvement of several other joints. Usually, in rheumatoid arthritis, there is always a case of inflammation which is a sure sign of the disease.
In regards to rheumatism, Arava is a drug that is specially designed to improve the symptoms of rheumatoid arthritis. It is the first isoxazol derivative that has been approved to treat rheumatoid arthritis. These symptoms include tenderness of the
joints and joint swelling.
Araya use and advantages:
* The advantage of Arava (leflunomide) is that while it has the ability to relieve symptoms of rheumatoid arthritis.
* It can help slow down the progression of joint damage.
* Arava can help alleviate and treat practically all stage of the adult forms of rheumatoid arthritis.
* It can also be used in tandem with other medicines to treat the pain and inflammation brought about by the disease.
On one hand, there are other drugs used to treat the inflammation and pains of rheumatoid arthritis that are compatible with Arava are non-steroidal anti-inflammatory drugs such as ibuprofen, salicylates and aspirin. Prior to you receiving Araya prescription, it is important that you communicate with your medical practitioner your current situation:
* you have an alcohol problem
* you are pregnant or trying to
* you are breastfeeding
* you are suffering from high blood pressure
* you have kidney, liver or lung diseases
* any allergies you might have, an immune deficiency, cancer and even a slight fever or an infection.
Arava is currently available as an oral medication. Doctor strongly suggests taking these tablets with a drink of water. It is recommended that patients take some food or even just drink milk when taking the tablets. In other words, it is not
recommended taking Arava on an empty stomach.
ARAVA NEWS HIGHLIGHTS
- FDA orders stronger warnings for 4 arthritis drugs
(AP) - FDA urges more caution over TNF blocker infections
(Reuters) - FDA orders stronger warnings for 4 arthritis drugs
(AP) - Pain relievers may complicate prostate screening
(Reuters) - Pain relievers may complicate prostate screening
(Reuters) - Resetting immune system in bid to beat scleroderma
(AP) - Successive births, HRT hard on the joints
(Reuters) - Rheumatoid Arthritis Treatment Doesn’t Promote Cancer
(HealthDay) - Rheumatoid Arthritis Treatment Doesn’t Promote Cancer
(HealthDay) - Rheumatoid Arthritis Treatment Doesn’t Promote Cancer
(HealthDay) - Rheumatoid Arthritis Treatment Doesn’t Promote Cancer
(HealthDay) - Hot flushes may predict breast cancer drug success
(Reuters) - Biologics Don’t Raise Cancer Risk in Rheumatoid Arthritis
Patients
(HealthDay) - Biologics Don’t Raise Cancer Risk in Rheumatoid Arthritis
Patients
(HealthDay) - Rituxan (rituximab) – PML
- Rituxan (rituximab) – PML
- High Blood Pressure Likely in Alzheimer’s Offspring
(HealthDay) - Cancer drug preserves insulin cells in diabetes
(Reuters) - Cancer drug preserves insulin cells in diabetes
(Reuters) - FDA advisers recommend approval of new gout drug
(AP) - Abused kids may grow up to have arthritis
(Reuters) - Abused kids may grow up to have arthritis
(Reuters) - Tight Management of Type 1 Diabetes Worth the Effort
(HealthDay) - UCB’s Cimzia (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
- FDA panel recommends ban on the painkiller Darvon
(AP) - Cutting Parkinson’s Drug Dose Linked to Withdrawal Effects
(HealthDay) - Cutting Parkinson’s Drug Dose Linked to Withdrawal Effects
(HealthDay) - Drugs can help symptoms of borderline personality
(Reuters) - Some blood pressure drugs may cut risk of dementia
(Reuters) - Experts promote baldness drug for prostate cancer
(Reuters) - Rheumatoid Arthritis Drugs Raise Shingles Risk
(HealthDay) - Changing habits may not lower blood pressure
(Reuters) - Health Tip: Warning Signs of Juvenile Arthritis
(HealthDay) - Health Tip: Warning Signs of Juvenile Arthritis
(HealthDay) - Alzheimer’s Drugs Also Treat Behavioral, Psych Problems
(HealthDay) - Conferences Prep Hospital Executives On Key Accreditation Updates
- FDA Advisory Committee Recommends Approval of Actemra (tocilizumab) for the Treatment of Rheumatoid Arthritis
- FDA Advisory Committee Recommends Approval of Actemra (tocilizumab) for the Treatment of Rheumatoid Arthritis
- Discovery Of How Rheumatoid Arthritis Causes Bone Loss Holds Implications For Autoimmune Disease And Osteoporosis
- Study Examines How Rheumatoid Arthritis Destroys Bone
- Hope over ‘early arthritis test’
- FDA Advisory Committee Recommends Approval of Actemra (tocilizumab) for the Treatment of Rheumatoid Arthritis
- Gene Behind Serious Statin Risk
- U.S. seeks warnings for Amylin diabetes drug
- U.S. seeks more warnings for Amylin diabetes drug
- Joint Symptoms More Likely For Some Breast Cancer Patients
- Scientists To Develop Rheumatoid Arthritis Vaccine
- Hope for arthritis vaccine ‘cure’
- Isis Initiates Clinical Trial Of CRP Drug
- Postmenopausal Women With Breast Cancer Face Joint Issues